Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 9 results for "herceptin"

US gives nod to Biocon-Mylan#39;s biosimilar of cancer drug Herceptin, revenues expected from FY19
Money Control

US gives nod to Biocon-Mylan#39;s biosimilar of cancer drug He...

Ogivri is the first FDA-approved biosimilar to Herceptin and the first biosimilar from Mylan and Biocon’s joint portfolio approved in the US Money Control, 1 month ago

4 images for herceptin

Money Today, 1 month ago
Business Standard, 1 month ago
Money Control, 1 month ago
Money Control, 1 month ago
Business Standard

Biocon surges 14% on USFDA approval for biosimilar of cancer drug Herceptin

The stock surged 14% to Rs 510, also its all-time high on the BSE in early morning trade on back of heavy volumes. SI Reporter | Mumbai Last Updated at December 4, 2017 09:59 IST Biocon surged 14% to Rs 510, also its all-time high on the BSE in early morning ...
 Business Standard1 month ago Biocon surges 14% on USFDA nod for biosimilar of cancer drug  Business Standard1 month ago Biocon surgest 15% on USFDA approval  Deccan Herald1 month ago

South Korea's Samsung Bioepis says FDA to review Herceptin copy

SEOUL (Reuters) - South Korea's Samsung Bioepis Co Ltd said on Wednesday the U.S. Food and Drug Administration (FDA) has accepted for review its copy of Swiss drugmaker Roche's blockbuster breast cancer drug Herceptin for potential approval.
 Reuters4 weeks ago

Of Monetary Policy, IPO Analysis of Shalby Ltd and Top Stocks in Action Today

Posted by Equitymaster Monetary Policy to Keep the Markets Volatile in the Next Few Days After shedding off 770 points on concerns over fiscal deficit in the previous week, there was some marginal relief as the S&P BSE Sensex ended yesterday's trade in the ...
 Equitymaster.com1 month ago
Sify

Biocon hits record high on US FDA approval for generic cancer drug Ogivri

Biocon Ltd jumps as much as 13.8 pct to hit a record high of 509.00 rupees. The biopharmaceutical company and its partner Mylan NV get U.S. FDA approval for Ogivri, biosimilar of Herceptin - used as a treatment for breast cancer. This is the first U.S./EU ...
 Sify1 month ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less